Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin versus oxytocin for prevention of postpartum hemorrhage after cesarean section
IRCT20140420017365N5Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Aug 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in postpartum hemorrhage (PPH) comparing Carbetocin arm with Oxytocin arm (2 arms). Primary endpoint: Incidence of postpartum hemorrhage. Started Aug 2025; status: completed.
02
Drugs
carbetocinoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT20140420017365N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140420017365N5.